<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">329983</id>
  <title nil="true"/>
  <common-name>N-(4-bromo-2-methylphenyl)-2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name>
  <description>N-(4-bromo-2-methylphenyl)-2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C22H17BrClN5OS. With an average molecular weight of 514.80 g/mol, N-(4-bromo-2-methylphenyl)-2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description>
  <cas>476483-89-3</cas>
  <pubchem-id>1544110</pubchem-id>
  <chemical-formula>C22H17BrClN5OS</chemical-formula>
  <weight>514.8</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T10:26:15Z</created-at>
  <updated-at type="dateTime">2026-08-30T10:26:15Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C(C=CC(=C1)Br)NC(=O)CSC2=NN=C(N2C3=CC=C(C=C3)Cl)C4=CC=NC=C4</moldb-smiles>
  <moldb-formula>C22H17BrClN5OS</moldb-formula>
  <moldb-inchi>InChI=1S/C22H17BrClN5OS/c1-14-12-16(23)2-7-19(14)26-20(30)13-31-22-28-27-21(15-8-10-25-11-9-15)29(22)18-5-3-17(24)4-6-18/h2-12H,13H2,1H3,(H,26,30)</moldb-inchi>
  <moldb-inchikey>CHVXWLLAEPBLOM-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.00257</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM325876</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-(4-bromo-2-methylphenyl)-2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Pyridyltriazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0280540</sync-id>
  <structure-inchikey>CHVXWLLAEPBLOM-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000200000800000000800000000000000000000000080004000000000000000080000000004008000002180000000000000000000000000200000000000000080400000000000000000000020000000000000000000800010000200000000010080000000000000100000000400000100000000000000000000000000000040020000000000000000000084880000010000800080000000000000000040000000000000000000080100000000000020410000000000002c00000000000000000000001000000100000000000010000000002000000200000000000000008040000000802040000000000400000008010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle>ï¾­Þ��������������������"���€���`������@(������@(������@h�������@h�������@(������@h������#� ������h��������(�������(�������`������� �����@(������@(������@(������@(������@(������@(������@h�������@h�������@(������@h�������@h�������� �����@(������@h�������@h�������@(������@h�������@h������������h���h���h���h���h������ �	 	
(�	��������h���h���h���h��� ��h���h���h���h���h������ ��h���h���h���h���h���h��h���h���h�B����������������������������������������</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:32:39Z</structure-indexed-at>
</compound>
